1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Wesana Health Holdings Inc.
  6. News
  7. Summary
    WESA   CA95081C1059

WESANA HEALTH HOLDINGS INC.

(WESA)
  Report
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  09:36 2022-06-27 am EDT
0.2100 CAD   +5.00%
06/08WESANA HEALTH CEO DANIEL CARCILLO TO KEYNOTE CHARLES RIVER SYMPOSIUM : Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies
AQ
05/31Wesana Announces First Quarter 2022 Financial Results
AQ
05/31Wesana Health Holdings Inc. Announces Resignation of Chad Bronstein as Executive Chairman
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Wesana Health Holdings Announces Review of Strategic Alternatives of its Clinics and Other Care Delivery Assets

05/05/2022 | 09:08am EDT

Wesana Health Holdings Inc. (CNSX:WESA) announced that following the successful completion of an initial tranche of its previously announced private placement, the company has determined to move forward with a strategic review of Wesana’s care delivery division. Strategic Rationale for Clinics and Other Care Delivery Asset Review: Feedback from the U.S. Food and Drug Administration (“FDA”) validates the company's strategic plan for simplification and growth. Given the clarity provided by FDA in the pre-IND meeting, and the Company’s increased focus on drug development, Wesana has commenced a strategic review of the Company’s assets with a focus on reviewing Wesana’s care delivery division. The Company is reviewing strategic alternatives including, but not limited to, a sale of all the assets under the care delivery division, including: Wesana Clinics – a network of psychiatrist-led mental health clinics focused on serving the community through the delivery of personalized innovative psychiatric care, inclusive of ketamine therapy, medication management, psychotherapy, cognitive testing, and pharmacogenetic testing. Wesana Solutions – a medical-grade clinical SaaS platform focused on improving mental healthcare through facilitating access to leading edge clinical protocols and tracking their efficacy. In concert with EMRs and practice management systems, Wesana Solutions is intended to be used in clinics delivering psychedelics and related therapies, targeting the developing international psychiatric clinic and research market. PsyTech Connect – a leading community for the clinical use of psychedelics with over 8,000 actively engaged professionals Zed Wang, Chief Financial Officer said, “We believe now is the correct time to review all strategic options to maximize shareholder value and financial resources. A clear focus will allow Wesana to optimize resources as we look to expand the lead indication associated with SANA-013 and allow the clinics to realize their growth potential”.


© S&P Capital IQ 2022
All news about WESANA HEALTH HOLDINGS INC.
06/08WESANA HEALTH CEO DANIEL CARCILLO TO : Re-Imagining Substance Abuse, Addiction, and Mental..
AQ
05/31Wesana Announces First Quarter 2022 Financial Results
AQ
05/31Wesana Health Holdings Inc. Announces Resignation of Chad Bronstein as Executive Chairm..
CI
05/30Wesana Health Holdings Inc. Reports Earnings Results for the First Quarter Ended March ..
CI
05/10Wesana Health Outlines Accelerated Drug Development Pathway
AQ
05/10Wesana Health Holdings Outlines Accelerated Drug Development Pathway
CI
05/05Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its..
AQ
05/05Wesana Health Holdings Announces Review of Strategic Alternatives of its Clinics and Ot..
CI
05/02Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highligh..
AQ
05/02Wesana Health Holdings Inc. Reports Earnings Results for the Full Year Ended December 3..
CI
More news
Financials (USD)
Sales 2022 1,56 M - -
Net income 2022 -21,8 M - -
Net Debt 2022 - - -
P/E ratio 2022 -0,31x
Yield 2022 -
Capitalization 3,14 M 3,14 M -
Capi. / Sales 2022 2,02x
Capi. / Sales 2023 1,15x
Nbr of Employees -
Free-Float 99,1%
Chart WESANA HEALTH HOLDINGS INC.
Duration : Period :
Wesana Health Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 0,15 $
Average target price 3,09 $
Spread / Average Target 1 896%
EPS Revisions
Managers and Directors
Daniel Carcillo Chief Executive Officer & Director
Zed Wang Chief Financial Officer & Secretary
Chad Bronstein Executive Chairman
Mark Wingertzahn Chief Scientific Officer
Mitchell Kahn Director
Sector and Competitors
1st jan.Capi. (M$)
WESANA HEALTH HOLDINGS INC.-86.01%3
MODERNA, INC.-43.20%57 385
IQVIA HOLDINGS INC.-24.22%40 468
LONZA GROUP AG-32.67%39 851
SEAGEN INC.16.00%33 010
CELLTRION, INC.-13.38%18 371